Therapeutic potential of targeting glutamate receptors in Parkinson’s disease
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Therapeutic potential of targeting glutamate receptors in Parkinson’s disease
Authors
Keywords
Akinesia, AMPA receptor, <span class=EmphasisTypeSmallCaps >l, Metabotropic glutamate receptor, Neurodegeneration, NMDA receptor, Non-motor symptoms
Journal
JOURNAL OF NEURAL TRANSMISSION
Volume 121, Issue 8, Pages 861-880
Publisher
Springer Nature
Online
2014-02-20
DOI
10.1007/s00702-014-1176-4
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Alternative splicing of AMPA receptor subunits in the 6-OHDA-lesioned rat model of Parkinson's disease and L-DOPA-induced dyskinesia
- (2013) Christopher Kobylecki et al. EXPERIMENTAL NEUROLOGY
- Chronic treatment with MPEP, an mGlu5 receptor antagonist, normalizes basal ganglia glutamate neurotransmission in l-DOPA-treated parkinsonian monkeys
- (2013) Nicolas Morin et al. NEUROPHARMACOLOGY
- Nociceptive brain activation in patients with neuropathic pain related to Parkinson's disease
- (2013) Christine Brefel-Courbon et al. PARKINSONISM & RELATED DISORDERS
- The Action of Antidepressants on the Glutamate System: Regulation of Glutamate Release and Glutamate Receptors
- (2012) Laura Musazzi et al. BIOLOGICAL PSYCHIATRY
- A Randomized Trial of a Low-Trapping Nonselective N-Methyl-D-Aspartate Channel Blocker in Major Depression
- (2012) Carlos A. Zarate et al. BIOLOGICAL PSYCHIATRY
- Allosteric modulation of the group III mGlu4 receptor provides functional neuroprotection in the 6-hydroxydopamine rat model of Parkinson's disease
- (2012) Matthew J Betts et al. BRITISH JOURNAL OF PHARMACOLOGY
- Perampanel in Parkinson Disease Fluctuations
- (2012) Olivier Rascol et al. CLINICAL NEUROPHARMACOLOGY
- Management of Pain in Parkinson’s Disease
- (2012) Munazza Sophie et al. CNS DRUGS
- Investigation of the antidyskinetic site of action of metabotropic and ionotropic glutamate receptor antagonists. Intracerebral infusions in 6-hydroxydopamine-lesioned rats with levodopa-induced dyskinesia
- (2012) Sotirios Maranis et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Memantine for axial signs in Parkinson's disease: a randomised, double-blind, placebo-controlled pilot study
- (2012) C. Moreau et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Potential of D-cycloserine in the treatment of behavioral and neuroinflammatory disorders in Parkinson's disease and studies that need to be performed before clinical trials
- (2012) Cornelius Rainer Pawlak et al. KAOHSIUNG JOURNAL OF MEDICAL SCIENCES
- Glutamate-based depression GBD
- (2012) Dennis J. McCarthy et al. MEDICAL HYPOTHESES
- Localization of mGluR5, GABAB, GABAA, and cannabinoid receptors on the vago-vagal reflex pathway responsible for transient lower esophageal sphincter relaxation in humans: an immunohistochemical study
- (2012) W. O. Rohof et al. NEUROGASTROENTEROLOGY AND MOTILITY
- Drebrin immunoreactivity in the striatum of a rat model of levodopa-induced dyskinesia
- (2012) Haruo Nishijima et al. NEUROPATHOLOGY
- The metabotropic glutamate receptor 8 agonist (S)-3,4-DCPG reverses motor deficits in prolonged but not acute models of Parkinson's disease
- (2012) Kari A. Johnson et al. NEUROPHARMACOLOGY
- MPEP, an mGlu5 receptor antagonist, reduces the development of l-DOPA-induced motor complications in de novo parkinsonian monkeys: Biochemical correlates
- (2012) Nicolas Morin et al. NEUROPHARMACOLOGY
- Anxiolytic- but not antidepressant-like activity of Lu AF21934, a novel, selective positive allosteric modulator of the mGlu4 receptor
- (2012) Anna Sławińska et al. NEUROPHARMACOLOGY
- Synergy between l-DOPA and a novel positive allosteric modulator of metabotropic glutamate receptor 4: Implications for Parkinson's disease treatment and dyskinesia
- (2012) Khaled-Ezaheir Bennouar et al. NEUROPHARMACOLOGY
- Blockade of metabotropic glutamate receptors inhibits cognition and neurodegeneration in an MPTP-induced Parkinson's disease rat model
- (2012) Ming-Hong Hsieh et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
- Randomised clinical trial: effects of monotherapy with ADX10059, a mGluR5 inhibitor, on symptoms and reflux events in patients with gastro-oesophageal reflux disease
- (2011) F. Zerbib et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Effects of d-cycloserine on MPTP-induced behavioral and neurological changes: Potential for treatment of Parkinson's disease dementia
- (2011) Ying-Jui Ho et al. BEHAVIOURAL BRAIN RESEARCH
- Metabotropic glutamate receptor 5 antagonist protects dopaminergic and noradrenergic neurons from degeneration in MPTP-treated monkeys
- (2011) G. J. Masilamoni et al. BRAIN
- Glutamate NMDA receptor dysregulation in Parkinson’s disease with dyskinesias
- (2011) Imtiaz Ahmed et al. BRAIN
- Chronic, systemic treatment with a metabotropic glutamate receptor 5 antagonist produces anxiolytic-like effects and reverses abnormal firing activity of projection neurons in the basolateral nucleus of the amygdala in rats with bilateral 6-OHDA lesions
- (2011) Li Chen et al. BRAIN RESEARCH BULLETIN
- Animal models of Parkinson's disease: a source of novel treatments and clues to the cause of the disease
- (2011) Susan Duty et al. BRITISH JOURNAL OF PHARMACOLOGY
- Antiparkinsonian potential of targeting group III metabotropic glutamate receptor subtypes in the rodent substantia nigra pars reticulata
- (2011) M Broadstock et al. BRITISH JOURNAL OF PHARMACOLOGY
- Local modulation of striatal glutamate efflux by serotonin 1A receptor stimulation in dyskinetic, hemiparkinsonian rats
- (2011) Kristin B. Dupre et al. EXPERIMENTAL NEUROLOGY
- Discovery, Synthesis, and Structure–Activity Relationship Development of a Series ofN-4-(2,5-Dioxopyrrolidin-1-yl)phenylpicolinamides (VU0400195, ML182): Characterization of a Novel Positive Allosteric Modulator of the Metabotropic Glutamate Receptor 4 (mGlu4) with Oral Efficacy in an Antiparkinsonian Animal Model
- (2011) Carrie K. Jones et al. JOURNAL OF MEDICINAL CHEMISTRY
- The Metabotropic Glutamate Receptor 7 Allosteric Modulator AMN082: A Monoaminergic Agent in Disguise?
- (2011) S. J. Sukoff Rizzo et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- mGlu2 Metabotropic Glutamate Receptors Restrain Inflammatory Pain and Mediate the Analgesic Activity of Dual mGlu2/mGlu3 Receptor Agonists
- (2011) Magda Zammataro et al. Molecular Pain
- Perampanel, an AMPA antagonist, found to have no benefit in reducing “off” time in Parkinson's disease
- (2011) Andrew Lees et al. MOVEMENT DISORDERS
- Etiology and pathogenesis of Parkinson's disease
- (2011) Anthony H. Schapira et al. MOVEMENT DISORDERS
- AFQ056 treatment of levodopa-induced dyskinesias: Results of 2 randomized controlled trials
- (2011) Daniela Berg et al. MOVEMENT DISORDERS
- Targeting NR2A-containing NMDA receptors reduces L-DOPA-induced dyskinesias
- (2011) Fabrizio Gardoni et al. NEUROBIOLOGY OF AGING
- GluR1 Phosphorylation and Persistent Expression of Levodopa-induced Motor Response Alterations in the Hemi-Parkinsonian Rat
- (2011) Maowen Ba et al. NEUROCHEMICAL RESEARCH
- Amantadine protects dopamine neurons by a dual action: Reducing activation of microglia and inducing expression of GNDF in astroglia
- (2011) Bernardino Ossola et al. NEUROPHARMACOLOGY
- Spinal metabotropic glutamate receptor 4 is involved in neuropathic pain
- (2011) Hua Wang et al. NEUROREPORT
- The acute antiparkinsonian and antidyskinetic effect of AFQ056, a novel metabotropic glutamate receptor type 5 antagonist, in l-Dopa-treated parkinsonian monkeys
- (2011) Laurent Grégoire et al. PARKINSONISM & RELATED DISORDERS
- Striatal plasticity in Parkinson's disease and L-DOPA induced dyskinesia
- (2011) M.M. Iravani et al. PARKINSONISM & RELATED DISORDERS
- Glutamatergic mechanisms in the dyskinesias induced by pharmacological dopamine replacement and deep brain stimulation for the treatment of Parkinson's disease
- (2011) Véronique Sgambato-Faure et al. PROGRESS IN NEUROBIOLOGY
- Increased plasma glutamate, glycine, and arginine levels in complex regional pain syndrome type 1
- (2010) F. WESSELDIJK et al. ACTA ANAESTHESIOLOGICA SCANDINAVICA
- Effects of early and delayed treatment with an mGluR5 antagonist on motor impairment, nigrostriatal damage and neuroinflammation in a rodent model of Parkinson's disease
- (2010) G. Ambrosi et al. BRAIN RESEARCH BULLETIN
- Therapeutic potential of targeting group III metabotropic glutamate receptors in the treatment of Parkinson's disease
- (2010) Susan Duty BRITISH JOURNAL OF PHARMACOLOGY
- Symptomatic and neuroprotective effects following activation of nigral group III metabotropic glutamate receptors in rodent models of Parkinson's disease
- (2010) PJ Austin et al. BRITISH JOURNAL OF PHARMACOLOGY
- Mechanisms underlying morphine analgesic tolerance and dependence
- (2010) Hiroshi Ueda Frontiers in Bioscience-Landmark
- Design and Synthesis of an Orally Active Metabotropic Glutamate Receptor Subtype-2 (mGluR2) Positive Allosteric Modulator (PAM) That Decreases Cocaine Self-Administration in Rats
- (2010) Raveendra-Panickar Dhanya et al. JOURNAL OF MEDICINAL CHEMISTRY
- Calcium-permeable AMPA receptors are involved in the induction and expression of l-DOPA-induced dyskinesia in Parkinson’s disease
- (2010) Christopher Kobylecki et al. JOURNAL OF NEUROCHEMISTRY
- The clinical spectrum of levodopa-induced motor complications
- (2010) E. Hametner et al. JOURNAL OF NEUROLOGY
- Management of punding in Parkinson’s disease: an open-label prospective study
- (2010) A. Fasano et al. JOURNAL OF NEUROLOGY
- Impaired Glial Glutamate Uptake Induces Extrasynaptic Glutamate Spillover in the Spinal Sensory Synapses of Neuropathic Rats
- (2010) Hui Nie et al. JOURNAL OF NEUROPHYSIOLOGY
- Ameliorative Effect of a Hippocampal Metabotropic Glutamate– Receptor Agonist on Histamine H1 Receptor Antagonist–Induced Memory Deficit in Rats
- (2010) Takayoshi Masuoka et al. JOURNAL OF PHARMACOLOGICAL SCIENCES
- Reduction of L-DOPA-Induced Dyskinesia by the Selective Metabotropic Glutamate Receptor 5 Antagonist 3-[(2-Methyl-1,3-thiazol-4-yl)ethynyl]pyridine in the 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-Lesioned Macaque Model of Parkinson's Disease
- (2010) T. H. Johnston et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- N-(4-((2-(trifluoromethyl)-3-hydroxy-4-(isobutyryl)phenoxy)methyl)benzyl)-1-methyl-1H-imidazole-4-carboxamide (THIIC), a Novel Metabotropic Glutamate 2 Potentiator with Potential Anxiolytic/Antidepressant Properties: In Vivo Profiling Suggests a Link between Behavioral and Central Nervous System Neurochemical Changes
- (2010) M. J. Fell et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Levodopa-induced dyskinesias in patients with Parkinson's disease: filling the bench-to-bedside gap
- (2010) Paolo Calabresi et al. LANCET NEUROLOGY
- Memantine for patients with Parkinson's disease dementia or dementia with Lewy bodies: a randomised, double-blind, placebo-controlled trial
- (2010) Murat Emre et al. LANCET NEUROLOGY
- Targeting Group II Metabotropic Glutamate (mGlu) Receptors for the Treatment of Psychosis Associated with Alzheimer's Disease: Selective Activation of mGlu2 Receptors Amplifies -Amyloid Toxicity in Cultured Neurons, Whereas Dual Activation of mGlu2 and mGlu3 Receptors Is Neuroprotective
- (2010) F. Caraci et al. MOLECULAR PHARMACOLOGY
- Long-term antidyskinetic efficacy of amantadine in Parkinson's disease
- (2010) Elisabeth Wolf et al. MOVEMENT DISORDERS
- Safety and efficacy of perampanel in advanced Parkinson's disease: A randomized, placebo-controlled study
- (2010) Karla Eggert et al. MOVEMENT DISORDERS
- A mGluR5 antagonist under clinical development improves L-DOPA-induced dyskinesia in parkinsonian rats and monkeys
- (2010) Daniella Rylander et al. NEUROBIOLOGY OF DISEASE
- Effect of the metabotropic glutamate receptor type 5 antagonists MPEP and MTEP in parkinsonian monkeys
- (2010) Nicolas Morin et al. NEUROPHARMACOLOGY
- Metabotropic glutamate receptor 4 novel agonist LSP1-2111 with anxiolytic, but not antidepressant-like activity, mediated by serotonergic and GABAergic systems
- (2010) Joanna M. Wierońska et al. NEUROPHARMACOLOGY
- MK-801 inhibits l-DOPA-induced abnormal involuntary movements only at doses that worsen parkinsonism
- (2010) Melanie A. Paquette et al. NEUROPHARMACOLOGY
- Changes of AMPA receptors in MPTP monkeys with levodopa-induced dyskinesias
- (2010) B. Ouattara et al. NEUROSCIENCE
- NMDA Receptor Antagonists for the Treatment of Neuropathic Pain
- (2010) Susan Collins et al. PAIN MEDICINE
- Glutamate receptors, neurotoxicity and neurodegeneration
- (2010) Anthony Lau et al. PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY
- Distinct Changes in cAMP and Extracellular Signal-Regulated Protein Kinase Signalling in L-DOPA-Induced Dyskinesia
- (2010) Emanuela Santini et al. PLoS One
- Characterisation of the Expression of NMDA Receptors in Human Astrocytes
- (2010) Ming-Chak Lee et al. PLoS One
- Memantine Improves Cognition and Reduces Alzheimer’s-Like Neuropathology in Transgenic Mice
- (2009) Hilda Martinez-Coria et al. AMERICAN JOURNAL OF PATHOLOGY
- The identification of structurally novel, selective, orally bioavailable positive modulators of mGluR2
- (2009) Pier L. D’Alessandro et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Effects of low-dose intranasal (S)-ketamine in patients with neuropathic pain
- (2009) Volker Huge et al. EUROPEAN JOURNAL OF PAIN
- Electrophysiological and behavioral evidence that modulation of metabotropic glutamate receptor 4 with a new agonist reverses experimental parkinsonism
- (2009) Corinne Beurrier et al. FASEB JOURNAL
- A proof-of-concept study evaluating the effect of ADX10059, a metabotropic glutamate receptor-5 negative allosteric modulator, on acid exposure and symptoms in gastro-oesophageal reflux disease
- (2009) C Keywood et al. GUT
- Single-Dose Administration of MK-0657, an NR2B-Selective NMDA Antagonist, Does Not Result in Clinically Meaningful Improvement in Motor Function in Patients With Moderate Parkinson's Disease
- (2009) Carol Addy et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Metabotropic glutamate receptor subtype 4 selectively modulates both glutamate and GABA transmission in the striatum: implications for Parkinson’s disease treatment
- (2009) Dario Cuomo et al. JOURNAL OF NEUROCHEMISTRY
- Metabotropic Glutamate 7 Receptor Subtype Modulates Motor Symptoms in Rodent Models of Parkinson's Disease
- (2009) B. Greco et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Pharmacological Modulation of Glutamate Transmission in a Rat Model of L-DOPA-Induced Dyskinesia: Effects on Motor Behavior and Striatal Nuclear Signaling
- (2009) D. Rylander et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Memantine in patients with Parkinson's disease dementia or dementia with Lewy bodies: a double-blind, placebo-controlled, multicentre trial
- (2009) Dag Aarsland et al. LANCET NEUROLOGY
- Non-motor symptoms of Parkinson's disease: dopaminergic pathophysiology and treatment
- (2009) K Ray Chaudhuri et al. LANCET NEUROLOGY
- NMDA antagonist memantine improves levodopa-induced dyskinesias and “On-off” phenomena in Parkinson's disease
- (2009) Sara Varanese et al. MOVEMENT DISORDERS
- Metabotropic glutamate receptor type 5 in levodopa-induced motor complications
- (2009) Bazoumana Ouattara et al. NEUROBIOLOGY OF AGING
- Effect of non-dopaminergic drug treatment on Levodopa induced dyskinesias in MPTP monkeys: Common implication of striatal neuropeptides
- (2009) Mohamed Khalil Tamim et al. NEUROPHARMACOLOGY
- Novel Neuroprotective Mechanisms of Memantine: Increase in Neurotrophic Factor Release from Astroglia and Anti-Inflammation by Preventing Microglial Activation
- (2009) Hung-Ming Wu et al. NEUROPSYCHOPHARMACOLOGY
- Metabotropic glutamate mGluR5 receptor blockade opposes abnormal involuntary movements and the increases in glutamic acid decarboxylase mRNA levels induced by l-DOPA in striatal neurons of 6-hydroxydopamine-lesioned rats
- (2009) N. Yamamoto et al. NEUROSCIENCE
- Group II metabotropic glutamate receptor activation by agonist LY379268 treatment increases the expression of brain derived neurotrophic factor in the mouse brain
- (2009) V. Di Liberto et al. NEUROSCIENCE
- Activation of mGlu3 Receptors Stimulates the Production of GDNF in Striatal Neurons
- (2009) Giuseppe Battaglia et al. PLoS One
- Synaptic recruitment of AMPA glutamate receptor subunits in levodopa-induced dyskinesia in the MPTP-lesioned nonhuman primate
- (2009) Monty A. Silverdale et al. SYNAPSE
- Effects of glutamate and α2-noradrenergic receptor antagonists on the development of neurotoxicity produced by chronic rotenone in rats
- (2009) Mesbah Alam et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- Review: Improving symptom control in early Parkinson’s disease
- (2009) Stuart H. Isaacson et al. Therapeutic Advances in Neurological Disorders
- Alterations in N-methyl-d-aspartate receptor subunits in primary sensory neurons following acid-induced esophagitis in cats
- (2008) Banani Banerjee et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- Evaluation of behavioural effects of a selective NMDA NR1A/2B receptor antagonist in the unilateral 6-OHDA lesion rat model
- (2008) S.T. Warraich et al. BRAIN RESEARCH BULLETIN
- Behavioural effects of a selective NMDA NR1A/2B receptor antagonist in rats with unilateral 6-OHDA+parafascicular lesions
- (2008) L. Truong et al. BRAIN RESEARCH BULLETIN
- Memantine for Prophylaxis of Chronic Tension-Type Headache—A Double-Blind, Randomized, Crossover Clinical Trial
- (2008) K Lindelof et al. CEPHALALGIA
- NEUROPROTECTIVE EFFECTS OF A SELECTIVEN-METHYL-d-ASPARTATE NR2B RECEPTOR ANTAGONIST IN THE 6-HYDROXYDOPAMINE RAT MODEL OF PARKINSON'S DISEASE
- (2008) KR Leaver et al. CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY
- An Innovative Design to Establish Proof of Concept of the Antidepressant Effects of the NR2B Subunit Selective N-Methyl-D-Aspartate Antagonist, CP-101,606, in Patients With Treatment-Refractory Major Depressive Disorder
- (2008) Sheldon H. Preskorn et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Investigation on tolerance development to subchronic blockade of mGluR5 in models of learning, anxiety, and levodopa-induced dyskinesia in rats
- (2008) Andreas Gravius et al. JOURNAL OF NEURAL TRANSMISSION
- Gene Transfer of GLT-1, a Glial Glutamate Transporter, into the Spinal cord by Recombinant Adenovirus Attenuates Inflammatory and Neuropathic Pain in Rats
- (2008) Sanae Maeda et al. Molecular Pain
- Effects of a NR2B selective NMDA glutamate antagonist, CP-101,606, on dyskinesia and parkinsonism
- (2008) John G. Nutt et al. MOVEMENT DISORDERS
- Functional organization of the basal ganglia: Therapeutic implications for Parkinson's disease
- (2008) Jose A. Obeso et al. MOVEMENT DISORDERS
- Molecular mechanisms of L-DOPA-induced dyskinesia
- (2008) Peter Jenner NATURE REVIEWS NEUROSCIENCE
- Functional interaction between adenosine A2A and group III metabotropic glutamate receptors to reduce parkinsonian symptoms in rats
- (2008) Sebastien Lopez et al. NEUROPHARMACOLOGY
- Anatomy and function of group III metabotropic glutamate receptors in gastric vagal pathways
- (2008) Richard L. Young et al. NEUROPHARMACOLOGY
- Metabotropic Glutamate Receptors 5 Blockade Reverses Spatial Memory Deficits in a Mouse Model of Parkinson's Disease
- (2008) Elvira De Leonibus et al. NEUROPSYCHOPHARMACOLOGY
- Topiramate in managing impulse control disorders in Parkinson's disease
- (2008) Pedro Emilio Bermejo PARKINSONISM & RELATED DISORDERS
- Pruning and loss of excitatory synapses by the parkin ubiquitin ligase
- (2008) T. D. Helton et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- mGluR5 metabotropic glutamate receptors and dyskinesias in MPTP monkeys
- (2007) Pershia Samadi et al. NEUROBIOLOGY OF AGING
- Systemic administration of an mGluR5 antagonist, but not unilateral subthalamic lesion, counteracts l-DOPA-induced dyskinesias in a rodent model of Parkinson's disease
- (2007) Giovanna Levandis et al. NEUROBIOLOGY OF DISEASE
- Group III metabotropic glutamate receptors inhibit hyperalgesia in animal models of inflammation and neuropathic pain
- (2007) Cyril Goudet et al. PAIN
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started